Regulation of allograft survival by inhibitory FcγRIIb signaling

Journal of Immunology

Volumn 189, Issue 12, 2012, Pages 5694-5702

  Callaghan, Chris J ^a   Win, Thet Su ^a   Motallebzadeh, Reza ^a   Conlon, Thomas M ^a   Chhabra, Manu ^a   Harper, Inês ^a   Sivaganesh, Siva ^a   Bolton, Eleanor M ^a   Bradley, J Andrew ^a   Brownlie, Rebecca J ^b   Smith, Kenneth G C ^b   Pettigrew, Gavin J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FC RECEPTOR IIB; IMMUNOGLOBULIN G ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ACUTE GRAFT REJECTION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTERY DISEASE; ARTICLE; B LYMPHOCYTE; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CELL LINEAGE; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DISEASE SEVERITY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE SUBPOPULATION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UPREGULATION;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEP G2 CELLS; HUMANS; IMMUNOGLOBULIN G; ISOANTIBODIES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, IGG; SIGNAL TRANSDUCTION;

EID: 84871158451     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202084     Document Type: Article

References (69)

1. Smith, K. G. C., and M. R. Clatworthy. 2010. FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat. Rev. Immunol. 10: 328-343.
2. Nimmerjahn, F., and J. V. Ravetch. 2008. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.
3. Nimmerjahn, F., and J. V. Ravetch. 2006. Fcgamma receptors: old friends and new family members. Immunity 24: 19-28. (Pubitemid 43077197)
4. Willcocks, L. C., K. G. C. Smith, and M. R. Clatworthy. 2009. Low-affinity Fcgamma receptors, autoimmunity and infection. Expert Rev. Mol. Med. 11: e24.
5. Greenberg, S., P. Chang, and S. C. Silverstein. 1993. Tyrosine phosphorylation is required for Fc receptor-mediated phagocytosis in mouse macrophages. J. Exp. Med. 177: 529-534. (Pubitemid 23117104)
6. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J. V. Ravetch. 1994. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76: 519-529. (Pubitemid 24064172)
7. Niederer, H. A., M. R. Clatworthy, L. C. Willcocks, and K. G. C. Smith. 2010. FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 1183: 69-88.
8. Willcocks, L. C., E. J. Carr, H. A. Niederer, T. F. Rayner, T. N. Williams, W. Yang, J. A. Scott, B. C. Urban, N. Peshu, T. J. Vyse, et al. 2010. A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 107: 7881-7885.
9. Crowley, J. E., J. E. Stadanlick, J. C. Cambier, and M. P. Cancro. 2009. FcgammaRIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation. Blood 113: 1464-1473.
10. Clatworthy, M. R., and K. G. C. Smith. 2004. FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J. Exp. Med. 199: 717-723. (Pubitemid 38316438)
11. Takai, T., M. Ono, M. Hikida, H. Ohmori, and J. V. Ravetch. 1996. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 379: 346-349. (Pubitemid 26033077)
12. Niederer, H. A., L. C. Willcocks, T. F. Rayner, W. Yang, Y. L. Lau, T. N. Williams, J. A. Scott, B. C. Urban, N. Peshu, S. J. Dunstan, et al. 2010. Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum. Mol. Genet. 19: 3282-3294.
13. Clynes, R. A., T. L. Towers, L. G. Presta, and J. V. Ravetch. 2000. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat. Med. 6: 443-446. (Pubitemid 30208162)
14. Kissmeyer-Nielsen, F., S. Olsen, V. P. Petersen, and O. Fjeldborg. 1966. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 2: 662-665.
15. Meier-Kriesche, H. U., J. D. Schold, T. R. Srinivas, and B. Kaplan. 2004. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am. J. Transplant. 4: 378-383. (Pubitemid 38282293)
16. Hidalgo, L. G., P. M. Campbell, B. Sis, G. Einecke, M. Mengel, J. Chang, J. Sellares, J. Reeve, and P. F. Halloran. 2009. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am. J. Transplant. 9: 2532-2541.
17. Einecke, G., B. Sis, J. Reeve, M. Mengel, P. M. Campbell, L. G. Hidalgo, B. Kaplan, and P. F. Halloran. 2009. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am. J. Transplant. 9: 2520-2531.
18. Smith, J. D., N. R. Banner, I. M. Hamour, M. Ozawa, A. Goh, D. Robinson, P. I. Terasaki, and M. L. Rose. 2011. De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival. Am. J. Transplant. 11: 312-319.
19. Smith, J. D., I. M. Hamour, N. R. Banner, and M. L. Rose. 2007. C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation. Am. J. Transplant. 7: 2809-2815. (Pubitemid 350045767)
20. Mitchell, R. N. 2009. Graft vascular disease: immune response meets the vessel wall. Annu. Rev. Pathol. 4: 19-47.
21. Hirohashi, T., S. Uehara, C. M. Chase, P. DellaPelle, J. C. Madsen, P. S. Russell, and R. B. Colvin. 2010. Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am. J. Transplant. 10: 510-517.
22. Uehara, S., C. M. Chase, L. D. Cornell, J. C. Madsen, P. S. Russell, and R. B. Colvin. 2007. Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis. Am. J. Transplant. 7: 57-65. (Pubitemid 44952856)
23. Hancock, W. W., R. Buelow, M. H. Sayegh, and L. A. Turka. 1998. Antibody-induced transplant arteriosclerosis is prevented by graft expression of antioxidant and anti-apoptotic genes. Nat. Med. 4: 1392-1396. (Pubitemid 28553461)
24. Brownlie, R. J., K. E. Lawlor, H. A. Niederer, A. J. Cutler, Z. Xiang, M. R. Clatworthy, R. A. Floto, D. R. Greaves, P. A. Lyons, and K. G. C. Smith. 2008. Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb. J. Exp. Med. 205: 883-895. (Pubitemid 351549885)
25. McKenzie, I. F., G. M. Morgan, M. S. Sandrin, M. M. Michaelides, R. W. Melvold, and H. I. Kohn. 1979. B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse. J. Exp. Med. 150: 1323-1338. (Pubitemid 10132051)
26. Honjo, K., X. Xu, and R. P. Bucy. 2004. CD4+ T-cell receptor transgenic T cells alone can reject vascularized heart transplants through the indirect pathway of alloantigen recognition. Transplantation 77: 452-455. (Pubitemid 38209750)
27. Honjo, K., X. Yan Xu, J. A. Kapp, and R. P. Bucy. 2004. Evidence for cooperativity in the rejection of cardiac grafts mediated by CD4 TCR Tg T cells specific for a defined allopeptide. Am. J. Transplant. 4: 1762-1768. (Pubitemid 39434435)
28. Corry, R. J., H. J.Winn, and P. S. Russell. 1973. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16: 343-350.
29. Win, T. S., S. Rehakova, M. C. Negus, K. Saeb-Parsy, M. Goddard, T. M. Conlon, E. M. Bolton, J. A. Bradley, and G. J. Pettigrew. 2009. Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production. Circ Heart Fail 2: 361-369.
30. Stevens, J., K. H.Wiesmüller, P. J. Barker, P.Walden, G.W. Butcher, and E. Joly. 1998. Efficient generation of major histocompatibility complex class I-peptide complexes using synthetic peptide libraries. J. Biol. Chem. 273: 2874-2884. (Pubitemid 28133937)
31. Garboczi, D. N., D. T. Hung, and D. C. Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89: 3429-3433.
32. Taylor, A. L., S. L. Negus, M. Negus, E. M. Bolton, J. A. Bradley, and G. J. Pettigrew. 2007. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity. Transplantation 83: 931-937. (Pubitemid 46682735)
33. Fischbein, M. P., A. Ardehali, J. Yun, S. Schoenberger, H. Laks, Y. Irie, P. Dempsey, G. Cheng, M. C. Fishbein, and B. Bonavida. 2000. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants. J. Immunol. 165: 7316-7322. (Pubitemid 32001212)
34. Motallebzadeh, R., S. Rehakova, T. M. Conlon, T. S. Win, C. J. Callaghan, M. Goddard, E. M. Bolton, N. H. Ruddle, J. A. Bradley, and G. J. Pettigrew. 2012. Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses. FASEB J. 26: 51-62.
35. Bolland, S., and J. V. Ravetch. 2000. Spontaneous autoimmune disease in Fc (gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13: 277-285.
36. Bygrave, A. E., K. L. Rose, J. Cortes-Hernandez, J. Warren, R. J. Rigby, H. T. Cook, M. J. Walport, T. J. Vyse, and M. Botto. 2004. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2: E243.
37. Boross, P., V. L. Arandhara, J. Martin-Ramirez, M. L. Santiago-Raber, F. Carlucci, R. Flierman, J. van der Kaa, C. Breukel, J. W. Claassens, M. Camps, et al. 2011. The inhibiting Fc receptor for IgG, FcgRIIB, is a modifier of autoimmune susceptibility. J. Immunol. 187: 1304-1313.
38. Zurita, E., M. Chagoyen, M. Cantero, R. Alonso, A. González-Neira, A. López- Jiménez, J. A. López-Moreno, C. P. Landel, J. Benítez, F. Pazos, and L. Montoliu. 2011. Genetic polymorphisms among C57BL/6 mouse inbred strains. Transgenic Res. 20: 481-489.
39. Fabre, J. W. 1996. The role of polymorphic donor peptides in allograft recognition and rejection. Immunol. Rev. 154: 21-43. (Pubitemid 27047282)
40. Rogers, N. J., and R. I. Lechler. 2001. Allorecognition. Am. J. Transplant. 1: 97-102. (Pubitemid 33674147)
41. Conlon, T. M., K. Saeb-Parsy, J. L. Cole, R. Motallebzadeh, M. S. Qureshi, S. Rehakova, M. C. Negus, C. J. Callaghan, E. M. Bolton, J. A. Bradley, and G. J. Pettigrew. 2012. Germinal center alloantibody responses are mediated exclusively by indirect-pathway CD4 T follicular helper cells. J. Immunol. 188: 2643-2652.
42. Win, T. S., and G. J. Pettigrew. 2010. Humoral autoimmunity and transplant vasculopathy: when allo is not enough. Transplantation 90: 113-120.
43. Guriec, N., C. Daniel, K. Le Ster, E. Hardy, and C. Berthou. 2006. Cytokine-regulated expression and inhibitory function of FcgammaRIIB1 and -B2 receptors in human dendritic cells. J. Leukoc. Biol. 79: 59-70. (Pubitemid 43054250)
44. Boruchov, A. M., G. Heller, M. C. Veri, E. Bonvini, J. V. Ravetch, and J. W. Young. 2005. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J. Clin. Invest. 115: 2914-2923. (Pubitemid 41434419)
45. Dhodapkar, K. M., J. L. Kaufman, M. Ehlers, D. K. Banerjee, E. Bonvini, S. Koenig, R. M. Steinman, J. V. Ravetch, and M. V. Dhodapkar. 2005. Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells. Proc. Natl. Acad. Sci. USA 102: 2910-2915. (Pubitemid 40299890)
46. Minskoff, S. A., K. Matter, and I. Mellman. 1998. Fc gamma RII-B1 regulates the presentation of B cell receptor-bound antigens. J. Immunol. 161: 2079-2083. (Pubitemid 28397014)
47. Yamada, A., T. M. Laufer, A. J. Gerth, C. M. Chase, R. B. Colvin, P. S. Russell, M. H. Sayegh, and H. Auchincloss, Jr. 2003. Further analysis of the T-cell subsets and pathways of murine cardiac allograft rejection. Am. J. Transplant. 3: 23-27. (Pubitemid 36306819)
48. Desai, D. D., S. O. Harbers, M. Flores, L. Colonna, M. P. Downie, A. Bergtold, S. Jung, and R. Clynes. 2007. Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses. J. Immunol. 178: 6217-6226. (Pubitemid 46717404)
49. Rudge, E. U., A. J. Cutler, N. R. Pritchard, and K. G. C. Smith. 2002. Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc gamma RII-mediated B cell suppression. J. Exp. Med. 195: 1079-1085. (Pubitemid 34412010)
50. Venkatesh, J., D. Kawabata, S. Kim, X. Xu, P. Chinnasamy, E. Paul, B. Diamond, and C. M. Grimaldi. 2009. Selective regulation of autoreactive B cells by FcgammaRIIB. J. Autoimmun. 32: 149-157.
51. Paul, E., A. Nelde, A. Verschoor, and M. C. Carroll. 2007. Follicular exclusion of autoreactive B cells requires FcgammaRIIb. Int. Immunol. 19: 365-373. (Pubitemid 46523385)
52. Rahman, Z. S., B. Alabyev, and T. Manser. 2007. FcgammaRIIB regulates autoreactive primary antibody-forming cell, but not germinal center B cell, activity. J. Immunol. 178: 897-907. (Pubitemid 46095162)
53. Fukuyama, H., F. Nimmerjahn, and J. V. Ravetch. 2005. The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Nat. Immunol. 6: 99-106. (Pubitemid 40136701)
54. Tiller, T., J. Kofer, C. Kreschel, C. E. Busse, S. Riebel, S. Wickert, F. Oden, M. M. Mertes, M. Ehlers, and H. Wardemann. 2010. Development of self-reactive germinal center B cells and plasma cells in autoimmune Fc gammaRIIB-deficient mice. J. Exp. Med. 207: 2767-2778.
55. Xiang, Z., A. J. Cutler, R. J. Brownlie, K. Fairfax, K. E. Lawlor, E. Severinson, E. U. Walker, R. A. Manz, D. M. Tarlinton, and K. G. C. Smith. 2007. FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat. Immunol. 8: 419-429. (Pubitemid 46745417)
56. Victora, G. D., T. A. Schwickert, D. R. Fooksman, A. O. Kamphorst, M. Meyer-Hermann, M. L. Dustin, and M. C. Nussenzweig. 2010. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 143: 592-605.
57. Crotty, S. 2011. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29: 621-663.
58. Vinuesa, C. G., M. A. Linterman, C. C. Goodnow, and K. L. Randall. 2010. T cells and follicular dendritic cells in germinal center B-cell formation and selection. Immunol. Rev. 237: 72-89.
59. Kerfoot, S. M.,G.Yaari, J. R. Patel,K. L. Johnson,D.G.Gonzalez, S.H.Kleinstein, and A. M. Haberman. 2011. Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone. Immunity 34: 947-960.
60. Qi, H., J. L. Cannons, F. Klauschen, P. L. Schwartzberg, and R. N. Germain. 2008. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature 455: 764-769.
61. Xiu, Y., K. Nakamura, M. Abe, N. Li, X. S. Wen, Y. Jiang, D. Zhang, H. Tsurui, S. Matsuoka, Y. Hamano, et al. 2002. Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses. J. Immunol. 169: 4340-4346. (Pubitemid 35178207)
62. Pritchard, N. R., A. J. Cutler, S. Uribe, S. J. Chadban, B. J. Morley, and K. G. C. Smith. 2000. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII. Curr. Biol. 10: 227-230. (Pubitemid 30146790)
63. Floto, R. A., M. R. Clatworthy, K. R. Heilbronn, D. R. Rosner, P. A. MacAry, A. Rankin, P. J. Lehner, W. H. Ouwehand, J. M. Allen, N. A. Watkins, and K. G. C. Smith. 2005. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat. Med. 11: 1056-1058. (Pubitemid 41486826)
64. Kyogoku, C., H. M. Dijstelbloem, N. Tsuchiya, Y. Hatta, H. Kato, A. Yamaguchi, T. Fukazawa, M. D. Jansen, H. Hashimoto, J. G. van de Winkel, et al. 2002. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum. 46: 1242-1254. (Pubitemid 34525832)
65. McGaha, T. L., B. Sorrentino, and J. V. Ravetch. 2005. Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science 307: 590-593. (Pubitemid 40165683)
66. Zhang, Y., S. Liu, Y. Yu, T. Zhang, J. Liu, Q. Shen, and X. Cao. 2011. Immune complex enhances tolerogenecity of immature dendritic cells via FcγRIIb and promotes FcγRIIb-overexpressing dendritic cells to attenuate lupus. Eur. J. Immunol. 41: 1154-1164.
67. Nimmerjahn, F., and J. V. Ravetch. 2005. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310: 1510-1512. (Pubitemid 41746349)
68. Horton, H. M., S. Y. Chu, E. C. Ortiz, E. Pong, S. Cemerski, I. W. Leung, N. Jacob, J. Zalevsky, J. R. Desjarlais, W. Stohl, and D. E. Szymkowski. 2011. Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus. J. Immunol. 186: 4223-4233.
69. Veri, M. C., S. Burke, L. Huang, H. Li, S. Gorlatov, N. Tuaillon, G. J. Rainey, V. Ciccarone, T. Zhang, K. Shah, et al. 2010. Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffold. Arthritis Rheum. 62: 1933-1943.